Menu
Search
|

Menu

Close
X

IDEXX Laboratories Inc IDXX.OQ (NASDAQ Stock Exchange Global Select Market)

225.69 USD
+6.42 (+2.93%)
As of 8:00 PM GMT
chart
Previous Close 219.27
Open 219.04
Volume 220,130
3m Avg Volume 205,961
Today’s High 226.13
Today’s Low 219.04
52 Week High 256.22
52 Week Low 176.11
Shares Outstanding (mil) 87.28
Market Capitalization (mil) 13,874.24
Forward P/E 54.56
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.71 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY18
2,213
FY17
1,969
FY16
1,775
EPS (USD)
FY18
4.286
FY17
3.284
FY16
2.447
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
54.56
32.54
Price to Sales (TTM)
vs sector
7.45
8.39
Price to Book (MRQ)
vs sector
--
5.27
Price to Cash Flow (TTM)
vs sector
40.31
24.12
Total Debt to Equity (MRQ)
vs sector
--
16.02
LT Debt to Equity (MRQ)
vs sector
--
11.35
Return on Investment (TTM)
vs sector
40.45
13.82
Return on Equity (TTM)
vs sector
--
15.25

EXECUTIVE LEADERSHIP

Jonathan Ayers
Chairman of the Board, President, Chief Executive Officer, Since 2002
Salary: $800,000.00
Bonus: --
Brian McKeon
Chief Financial Officer, Executive Vice President, Treasurer, Since 2014
Salary: $549,538.00
Bonus: --
Giovani Twigge
Chief Human Resource Officer, Corporate Vice President, Since 2010
Salary: $379,308.00
Bonus: --
Jay Mazelsky
Executive Vice President, Since 2012
Salary: $469,462.00
Bonus: --
Sharon Underberg
Corporate Vice President, General Counsel, and Corporate Secretary, Since 2019
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1 Idexx Dr
WESTBROOK   ME   04092-2041

Phone: +1207.5560300

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic products and services for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements. Its products and services include point-of-care veterinary diagnostic products, comprising instruments, consumables and rapid assay test kits, among others.

SPONSORED STORIES